ATE340584T1 - Zusammensetzung und verfahren zur behandlung chronischer allograft-abstossung - Google Patents
Zusammensetzung und verfahren zur behandlung chronischer allograft-abstossungInfo
- Publication number
- ATE340584T1 ATE340584T1 AT02804721T AT02804721T ATE340584T1 AT E340584 T1 ATE340584 T1 AT E340584T1 AT 02804721 T AT02804721 T AT 02804721T AT 02804721 T AT02804721 T AT 02804721T AT E340584 T1 ATE340584 T1 AT E340584T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- allograft rejection
- chronic allograft
- treating chronic
- therapeutically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/006,562 US7368423B1 (en) | 2001-12-05 | 2001-12-05 | Composition and method for treating chronic allograft rejection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE340584T1 true ATE340584T1 (de) | 2006-10-15 |
Family
ID=21721475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02804721T ATE340584T1 (de) | 2001-12-05 | 2002-12-05 | Zusammensetzung und verfahren zur behandlung chronischer allograft-abstossung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7368423B1 (de) |
| EP (1) | EP1461062B1 (de) |
| JP (1) | JP2005530680A (de) |
| AT (1) | ATE340584T1 (de) |
| AU (1) | AU2002357062B2 (de) |
| CA (1) | CA2465120A1 (de) |
| CY (1) | CY1106242T1 (de) |
| DE (1) | DE60215051T2 (de) |
| DK (1) | DK1461062T3 (de) |
| ES (1) | ES2269825T3 (de) |
| HK (1) | HK1064610A1 (de) |
| MX (1) | MXPA04005097A (de) |
| PT (1) | PT1461062E (de) |
| WO (1) | WO2003049682A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105056207A (zh) | 2007-01-04 | 2015-11-18 | 德比奥法姆国际股份有限公司 | 用于治疗Ullrich先天性肌营养不良的非免疫抑制性环孢霉素 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5310732A (en) * | 1986-02-03 | 1994-05-10 | The Scripps Research Institute | 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis |
| WO1995032718A1 (en) * | 1994-05-26 | 1995-12-07 | The Scripps Research Institute | 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease |
| AR006514A1 (es) * | 1995-07-04 | 1999-09-08 | Sandoz Ag | Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende |
| DE19547648A1 (de) * | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
| JPH11228442A (ja) * | 1998-02-09 | 1999-08-24 | Cypros Pharmaceut Corp | 臓器移植後のシクロスポリン投与量を低減するためのフルクトース二リン酸の使用 |
-
2001
- 2001-12-05 US US10/006,562 patent/US7368423B1/en not_active Expired - Fee Related
-
2002
- 2002-12-05 DE DE60215051T patent/DE60215051T2/de not_active Expired - Lifetime
- 2002-12-05 DK DK02804721T patent/DK1461062T3/da active
- 2002-12-05 JP JP2003550733A patent/JP2005530680A/ja active Pending
- 2002-12-05 CA CA002465120A patent/CA2465120A1/en not_active Abandoned
- 2002-12-05 WO PCT/US2002/038628 patent/WO2003049682A2/en active IP Right Grant
- 2002-12-05 PT PT02804721T patent/PT1461062E/pt unknown
- 2002-12-05 ES ES02804721T patent/ES2269825T3/es not_active Expired - Lifetime
- 2002-12-05 EP EP02804721A patent/EP1461062B1/de not_active Expired - Lifetime
- 2002-12-05 AT AT02804721T patent/ATE340584T1/de active
- 2002-12-05 AU AU2002357062A patent/AU2002357062B2/en not_active Ceased
-
2004
- 2004-05-27 MX MXPA04005097A patent/MXPA04005097A/es active IP Right Grant
- 2004-10-05 HK HK04107636A patent/HK1064610A1/xx not_active IP Right Cessation
-
2006
- 2006-11-14 CY CY20061101654T patent/CY1106242T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1461062T3 (da) | 2007-01-08 |
| US7368423B1 (en) | 2008-05-06 |
| ES2269825T3 (es) | 2007-04-01 |
| MXPA04005097A (es) | 2004-08-19 |
| AU2002357062A1 (en) | 2003-06-23 |
| DE60215051T2 (de) | 2007-05-16 |
| HK1064610A1 (en) | 2005-02-04 |
| EP1461062A4 (de) | 2005-03-16 |
| PT1461062E (pt) | 2006-12-29 |
| CY1106242T1 (el) | 2011-06-08 |
| JP2005530680A (ja) | 2005-10-13 |
| WO2003049682A3 (en) | 2004-01-15 |
| EP1461062A2 (de) | 2004-09-29 |
| AU2002357062B2 (en) | 2007-08-02 |
| EP1461062B1 (de) | 2006-09-27 |
| CA2465120A1 (en) | 2003-06-19 |
| WO2003049682A2 (en) | 2003-06-19 |
| DE60215051D1 (de) | 2006-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| NL300056I1 (nl) | Toepassing van rapamycine en derivaten en vóórgeneesmiddelen daarvan bij de bereiding van een geneesmiddel voor het remmen van de afstoting van een transplantaat in zoogdieren. | |
| NZ527076A (en) | Graft rejection inhibitors used in combination with immunosuppressants | |
| WO2004100868A3 (en) | Method of treating transplant rejection | |
| ATE424893T1 (de) | Behandlung und vorbeugung von insulin- produzierende zelltransplantatabstossung | |
| CY1116107T1 (el) | Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων | |
| TR200101481T2 (tr) | Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi. | |
| EP3530288A3 (de) | Verfahren zur behandlung von leiden in zusammenhang mit masp-2-abhängiger komplementaktivierung | |
| ATE276764T1 (de) | Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen | |
| CO5700767A2 (es) | Procedimiento de tratamiento de rechazo de transplantes | |
| DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
| TW200640487A (en) | Combination of XOLAIR with immunosuppressive agent | |
| ATE538790T1 (de) | Scopolamin für die behandlung von depression und ängstlichkeit | |
| WO2006034001A3 (en) | Methods of treating hiv infection | |
| TR200200821T2 (tr) | 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı. | |
| SE0202598D0 (sv) | Alpha-7 Nicotinic receptor agonists and statins in combination | |
| ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
| AR027240A1 (es) | Combinacion de mirtazapina y gepirona para el tratamiento de la depresion y trastornos relacionados | |
| ES2055415T3 (es) | S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas. | |
| ATE297217T1 (de) | Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung | |
| WO2022023566A3 (en) | Cd-3 antibodies for the treatment of coronavirus | |
| ATE340584T1 (de) | Zusammensetzung und verfahren zur behandlung chronischer allograft-abstossung | |
| WO2005041877A3 (en) | Method of inhibiting rejection following organ transplantation | |
| ATE474590T1 (de) | Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen | |
| BR0115364A (pt) | Tratamento de disfunção sexual |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1461062 Country of ref document: EP |